| Dr Molly Plovanich, MD | |
|
784 Central Ave, Dover, NH 03820-2549 | |
| (603) 742-5556 | |
| (603) 742-8668 |
| Full Name | Dr Molly Plovanich |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 10 Years |
| Location | 784 Central Ave, Dover, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134532187 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 299025 (New York) | Secondary |
| 207R00000X | Internal Medicine | 259544 (Massachusetts) | Secondary |
| 207N00000X | Dermatology | 24773 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Strong Memorial Hospital | Rochester, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Rochester | 5799699088 | 814 |
| Campbell Dermatology Pa | 9537154059 | 15 |
News Archive
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the completion of enrollment in the TRYTON Pivotal IDE trial evaluating the Tryton Side Branch Stent.
Researchers at the Kennedy Krieger Institute announced today the results of a pilot study demonstrating use of a virtual therapeutic sailing simulator as an important part of rehabilitation following a spinal cord injury. Published in the American Journal of Physical Medicine & Rehabilitation, findings show that using a hands-on sailing simulator over a 12-week period helped participants safely learn sailing skills in a controlled environment, ultimately improving their quality of life by gaining the ability to participate in a recreational sport.
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and neurodegenerative diseases, today announces positive results from a recently completed clinical trial demonstrating the activity of GFT505 on glucose homeostasis. Results from the clinical trial (GFT505-2094) clearly demonstrate the potential of the drug candidate to reduce global cardiovascular risk in prediabetic patients who suffer from impaired fasting plasma glucose, impaired glucose tolerance, and abdominal obesity.
The National HIV/AIDS Strategy represents the nation's first comprehensive plan to reduce the impact of HIV/AIDS in this country. The strategy sets specific targets and provides detailed implementation information on the steps we must take to increase access to high quality HIV/AIDS care and treatment, decrease new HIV infections, and reduce HIV-related health disparities.
That midday wall you hit where you just can't stay awake may be an indicator of obstructed nasal passages and sleep-disordered breathing, according to a new study published in the October 2007 edition of Otolaryngology – Head and Neck Surgery .
› Verified 8 days ago
| Entity Name | University Of Rochester |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710226824 PECOS PAC ID: 5799699088 Enrollment ID: O20031201000019 |
News Archive
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the completion of enrollment in the TRYTON Pivotal IDE trial evaluating the Tryton Side Branch Stent.
Researchers at the Kennedy Krieger Institute announced today the results of a pilot study demonstrating use of a virtual therapeutic sailing simulator as an important part of rehabilitation following a spinal cord injury. Published in the American Journal of Physical Medicine & Rehabilitation, findings show that using a hands-on sailing simulator over a 12-week period helped participants safely learn sailing skills in a controlled environment, ultimately improving their quality of life by gaining the ability to participate in a recreational sport.
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and neurodegenerative diseases, today announces positive results from a recently completed clinical trial demonstrating the activity of GFT505 on glucose homeostasis. Results from the clinical trial (GFT505-2094) clearly demonstrate the potential of the drug candidate to reduce global cardiovascular risk in prediabetic patients who suffer from impaired fasting plasma glucose, impaired glucose tolerance, and abdominal obesity.
The National HIV/AIDS Strategy represents the nation's first comprehensive plan to reduce the impact of HIV/AIDS in this country. The strategy sets specific targets and provides detailed implementation information on the steps we must take to increase access to high quality HIV/AIDS care and treatment, decrease new HIV infections, and reduce HIV-related health disparities.
That midday wall you hit where you just can't stay awake may be an indicator of obstructed nasal passages and sleep-disordered breathing, according to a new study published in the October 2007 edition of Otolaryngology – Head and Neck Surgery .
› Verified 8 days ago
| Entity Name | University Dermatology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609802362 PECOS PAC ID: 5698736460 Enrollment ID: O20041025000732 |
News Archive
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the completion of enrollment in the TRYTON Pivotal IDE trial evaluating the Tryton Side Branch Stent.
Researchers at the Kennedy Krieger Institute announced today the results of a pilot study demonstrating use of a virtual therapeutic sailing simulator as an important part of rehabilitation following a spinal cord injury. Published in the American Journal of Physical Medicine & Rehabilitation, findings show that using a hands-on sailing simulator over a 12-week period helped participants safely learn sailing skills in a controlled environment, ultimately improving their quality of life by gaining the ability to participate in a recreational sport.
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and neurodegenerative diseases, today announces positive results from a recently completed clinical trial demonstrating the activity of GFT505 on glucose homeostasis. Results from the clinical trial (GFT505-2094) clearly demonstrate the potential of the drug candidate to reduce global cardiovascular risk in prediabetic patients who suffer from impaired fasting plasma glucose, impaired glucose tolerance, and abdominal obesity.
The National HIV/AIDS Strategy represents the nation's first comprehensive plan to reduce the impact of HIV/AIDS in this country. The strategy sets specific targets and provides detailed implementation information on the steps we must take to increase access to high quality HIV/AIDS care and treatment, decrease new HIV infections, and reduce HIV-related health disparities.
That midday wall you hit where you just can't stay awake may be an indicator of obstructed nasal passages and sleep-disordered breathing, according to a new study published in the October 2007 edition of Otolaryngology – Head and Neck Surgery .
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Molly Plovanich, MD 784 Central Ave, Dover, NH 03820-2549 Ph: (603) 742-5556 | Dr Molly Plovanich, MD 784 Central Ave, Dover, NH 03820-2549 Ph: (603) 742-5556 |
News Archive
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the completion of enrollment in the TRYTON Pivotal IDE trial evaluating the Tryton Side Branch Stent.
Researchers at the Kennedy Krieger Institute announced today the results of a pilot study demonstrating use of a virtual therapeutic sailing simulator as an important part of rehabilitation following a spinal cord injury. Published in the American Journal of Physical Medicine & Rehabilitation, findings show that using a hands-on sailing simulator over a 12-week period helped participants safely learn sailing skills in a controlled environment, ultimately improving their quality of life by gaining the ability to participate in a recreational sport.
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and neurodegenerative diseases, today announces positive results from a recently completed clinical trial demonstrating the activity of GFT505 on glucose homeostasis. Results from the clinical trial (GFT505-2094) clearly demonstrate the potential of the drug candidate to reduce global cardiovascular risk in prediabetic patients who suffer from impaired fasting plasma glucose, impaired glucose tolerance, and abdominal obesity.
The National HIV/AIDS Strategy represents the nation's first comprehensive plan to reduce the impact of HIV/AIDS in this country. The strategy sets specific targets and provides detailed implementation information on the steps we must take to increase access to high quality HIV/AIDS care and treatment, decrease new HIV infections, and reduce HIV-related health disparities.
That midday wall you hit where you just can't stay awake may be an indicator of obstructed nasal passages and sleep-disordered breathing, according to a new study published in the October 2007 edition of Otolaryngology – Head and Neck Surgery .
› Verified 8 days ago
Dr. Robert Delaney Murgia Iii, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 784 Central Ave, Dover, NH 03820 Phone: 603-742-5556 | |
Dr. Christina Marie Correnti, MD, MSCR Dermatology Medicare: Accepting Medicare Assignments Practice Location: 784 Central Ave, Dover, NH 03820 Phone: 603-742-5556 | |
Daniel O'connor, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 784 Central Ave, Dover, NH 03820 Phone: 603-742-5556 | |
Todd W Wechter, MD Dermatology Medicare: Medicare Enrolled Practice Location: 784 Central Ave, Dover, NH 03820 Phone: 603-742-5556 Fax: 603-742-8668 | |
Stephanie Emma Grant, FNP-C Dermatology Medicare: Not Enrolled in Medicare Practice Location: 784 Central Ave, Dover, NH 03820 Phone: 603-742-5556 | |
Gary Wayne Mendese, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 784 Central Ave, Dover, NH 03820 Phone: 603-742-5556 |